Clinical Trial Update: Neo-adjuvant Immunotherapy in Patients With Localized Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on neo-adjuvant immunotherapy for localized melanoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Mucosal Melanoma

Snippet

Sponsor: UNICANCER | Conditions: Cutaneous Melanoma, Stage III, Mucosal Melanoma | Phase 2 | Status: RECRUITING